Related Experiment Video
Updated: Sep 28, 2025

Inducible and Reversible Dominant-negative DN Protein Inhibition
Published on: January 7, 2019
Retinoblastoma Protein Paralogs and Tumor Suppression
Mauricio Flores1, David W Goodrich1
1Roswell Park Comprehensive Cancer Center, Department of Pharmacology and Therapeutics, Buffalo, NY, United States.
Abstract:
The retinoblastoma susceptibility gene (RB1) is the first tumor suppressor gene discovered and a prototype for understanding regulatory networks that function in opposition to oncogenic stimuli. More than 3 decades of research has firmly established a widespread and prominent role for RB1 in human cancer. Yet, this gene encodes but one of three structurally and functionally related proteins that comprise the pocket protein family. A central question in the field is whether the additional genes in this family, RBL1 and RBL2, are important tumor suppressor genes. If so, how does their tumor suppressor activity overlap or differ from RB1. Here we revisit these questions by reviewing relevant data from human cancer genome sequencing studies that have been rapidly accumulating in recent years as well as pertinent functional studies in genetically engineered mice. We conclude that RBL1 and RBL2 do have important tumor suppressor activity in some contexts, but RB1 remains the dominant tumor suppressor in the family. Given their similarities, we speculate on why RB1 tumor suppressor activity is unique.
Insights
The retinoblastoma susceptibility gene (RB1) is a key tumor suppressor. While RBL1 and RBL2 also suppress tumors, RB1 remains the most critical in the pocket protein family.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The retinoblastoma susceptibility gene (RB1) is the first identified tumor suppressor gene.
- RB1, RBL1, and RBL2 form the pocket protein family, crucial in opposing oncogenic stimuli.
- The roles of RBL1 and RBL2 as tumor suppressors compared to RB1 are not fully understood.
Purpose of the Study:
- To investigate the tumor suppressor functions of RBL1 and RBL2 in relation to RB1.
- To determine the overlapping and distinct roles of pocket proteins in cancer suppression.
- To understand the unique dominance of RB1 as a tumor suppressor.
Main Methods:
- Review of human cancer genome sequencing studies.
- Analysis of functional studies in genetically engineered mouse models.
- Comparative analysis of RB1, RBL1, and RBL2 functions.
Main Results:
- RBL1 and RBL2 exhibit tumor suppressor activity in certain contexts.
- RB1 demonstrates the most prominent tumor suppressor role within the pocket protein family.
- Significant similarities exist among RB1, RBL1, and RBL2, yet RB1's activity is unique.
Conclusions:
- RB1 is the predominant tumor suppressor gene in the pocket protein family.
- RBL1 and RBL2 contribute to tumor suppression, but to a lesser extent than RB1.
- Further research is needed to elucidate the specific mechanisms behind RB1's unique tumor suppressor activity.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

